Firmonertinib (previously referred to as alflutinib and furmonertinib) is targeted drug that that is approved in China for the treatment of non-small cell lung cancer (NSCLC).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.